New Lawsuit on Pulmonary Hypertension Moved to Fen Phen Multidistrict Litigation

According to court documents, on September 27th, 2012, the lawsuit filed by Lois Munchel in Delaware District Court (case no. 1:2012cv00906), alleging primary pulmonary hypertension from fenfluramine and phentermine, was transferred to the Fen Phen Multidistrict Litigation (MDL No. 1203). Fen Phen, a popular Wyeth obesity drug, was withdrawn from the market in 1997 as it was linked with heart valve damage and primary pulmonary hypertension (PPH). Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fen Phen severe adverse events. [http://www.attorneyone.com/fen-phen-lawsuits/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fen Phen: severe adverse events threat

Fen Phen: severe adverse events threat

as a result of this exposure plaintiff has developed primary pulmonary hypertension

San Diego, CA (PRWEB) November 14, 2012

The media spotlight is often a double-edged sword. No one knows this better than Lois Munchel. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on September 27th, 2012, the lawsuit filed by Lois Munchel in Delaware District Court (case no. 1:2012cv00906), alleging primary pulmonary hypertension from fenfluramine and phentermine, was transferred to the Phen Phen Multidistrict Litigation (MDL No. 1203, US District Court for the Eastern District of Pennsylvania). Fen Phen, a popular Wyeth obesity drug, was withdrawn from the market in 1997 as it was linked with heart valve damage and primary pulmonary hypertension (PPH).

In the lawsuit, plaintiff claims that in 1992 felfluramine and phentermine began to be widely prescribed and ingested in a combination popularly known as Fen Phen. Munchel was prescribed Pondimin (fenfluramine) and Phentermine in combination by her doctors from 1995 to 1996. As a result of this exposure plaintiff has developed primary pulmonary hypertension.

Findings of the 2008 study, published in BMC Medicine, indicate that many individuals that had taken Fen Phen in the past were found to have heart valve damage up to 7 years later.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Fen Phen, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fen Phen remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

As BusinessWeek reported on August 30th 2012, Pfizer Inc. whose Wyeth unit reserved more than $21 billion to settle lawsuits over the Fen Phen drug, lost its bid to have claims that the pills caused a fatal disease years after users stopped taking them thrown out (MDL No. 1203, US District Court for the Eastern District of Pennsylvania).

AttorneyOne informs you that if someone has already filed a claim and received a settlement but their condition deteriorated overtime they may be eligible for further compensation.
AttorneyOne.com has further information on Fen Phen lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/11/prweb10109022.htm.